1. Home
  2. Press release
Jul 11, 2019 12:00 JST

Source: Novotech Health Holdings Pte Ltd

Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

SINGAPORE / TOKYO, Jul 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

SuLyn Yip, Novotech Country Manager, and Dr Steven Thng, Executive Director of SRIS, signing the Partnership.
 

 


The Partnership formalizes a long-standing working relationship between the two, enabling closer collaboration to ensure the high priority start-up of new projects, and cooperation in clinical trial promotion, business development, networking opportunities, clinical operation, training, and feasibility assessment.

SRIS was established as a collaboration between Agency for Science, Technology and Research (A*STAR), National Healthcare Group (NHG) and Nanyang Technological University (NTU) to conduct high impact, inter-disciplinary skin research that would translate into improved health outcomes and quality of life.

Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.

Novotech CEO Dr John Moller said the Partnership with SRIS will support the increasing demand from biotech clients for skin disorder studies in the Asia-Pacific region.

Please visit the Skin Research Institute of Singapore (SRIS)at https://www.a-star.edu.sg/sris/About-SRIS.

About Novotech:
Headquartered in Sydney, Novotech CRO is the internationally recognized Asia Pacific contract research organization (CRO) instrumental in hundreds of clinical trials across the region. https://novotech-cro.com/welcome
Check if Asia Pacific is right for your next study: https://novotechcro.typeform.com/to/Uwizka
For RFP enquiries, please fill out the form available at www.novotech-cro.com/contact-us-0

Media contact:
communications@novotech-cro.com
Susan Fitzpatrick-Napier
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427

Source: Novotech Health Holdings Pte Ltd
Sectors: Healthcare & Pharm

Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Related Press Release

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
February 15 2023 09:00 JST
 
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
February 10 2023 19:00 JST
 
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
February 03 2023 13:00 JST
 
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
January 12 2023 15:00 JST
 
Novotech Acquires European CRO, Strengthens Global Operations
January 12 2023 15:00 JST
 
Novotech is Gold Sponsor at Biotech Showcase 2023
December 20 2022 11:00 JST
 
Data Shows 50% of New Trials Have Sites in Asia Pacific
December 15 2022 10:00 JST
 
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
December 06 2022 11:00 JST
 
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
November 11 2022 17:00 JST
 
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper
October 25 2022 18:00 JST
 
More Press release >>

Latest Press Release


Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST

Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST

New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST

TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST

Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST

MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST

Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST

DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST

Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST

Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST

DENSO, Companies Initiate Demonstration to Expand Automotive Recycling Process
Apr 09, 2024 19:07 JST

Mitsubishi Power Receives Order from HK Electric for Natural-gas-fired GTCC Power Generation Equipment
Apr 09, 2024 15:04 JST

MHI Thermal Systems Adds New KXZ3 Series of Building-use Multi-Split Air- Conditioners Adopting R32 Refrigerant
Apr 09, 2024 13:40 JST

Fujitsu AI transforms manufacturing lines with new quality control system for REHAU
Apr 09, 2024 10:39 JST

NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
Apr 08, 2024 13:45 JST

Daihatsu and Toyota to Reform Structures towards the Revitalization of Daihatsu
Apr 08, 2024 13:37 JST

Hitachi Energy and SP Energy Networks to boost renewable energy flow
Apr 05, 2024 17:15 JST

Hitachi Selected as "Excellent TCFD Disclosure" by GPIF's External Asset Managers for the Third Consecutive Year
Apr 05, 2024 17:00 JST

Mitsubishi Corporation: Sale of BMA Coal Assets in Queensland Completed
Apr 03, 2024 19:05 JST
 More Latest Release >>